Micronutrients & recovery
Supplementing with NAD+ precursors (specifically Nicotinamide Riboside or Nicotinamide Mononucleotide) or inhibiting NAD+-consuming enzymes (PARP/CD38) restores mitochondrial function and improves metabolic health in models of mitochondrial disease, aging, and age-related disorders.
Current evidence from animal and cell models suggests that maintaining or boosting NAD+ levels via precursors (like NR or NMN) or lifestyle factors (fasting, exercise) may support mitochondrial health and metabolic function, particularly in aging or disease states. However, optimal dosing, safety, and efficacy in healthy humans remain to be determined by future clinical trials.
Increasing cellular NAD+ content by inducing its biosynthesis or inhibiting the activity of PARP and cADP-ribose synthases via genetic or pharmacological means lead to sirtuins activation... augmenting intracellular NAD+ content increases oxidative metabolism to prevent bioenergetic and functional decline in multiple models of mitochondrial diseases and age-related disorders.
Why this rating
The paper is a review of preclinical models (mice, worms, cell cultures); no human clinical trial data is presented, limiting direct applicability to humans.
Source
Emerging therapeutic roles for NAD<sup>+</sup> metabolism in mitochondrial and age‐related disorders
Sarika Srivastava · Clinical and Translational Medicine · 2016
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →